v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenues $ 657,235 $ 1,268,447 $ 1,705,319 $ 3,857,273
Cost of Sales 772,238 1,015,843 1,373,739 2,882,705
Gross Profit (115,003) 252,604 331,580 974,568
General and Administrative Expenses        
Stock compensation and stock issued for services   78,102 238,128 110,852
Impairment expense   46,869
General and administrative 667,185 1,126,705 3,610,456 3,627,953
Total General and Administrative Expenses 667,185 1,204,807 3,848,548 3,785,674
Loss from Operations (782,188) (952,203) (3,517,004) (2,811,106)
Other Income (Expense)        
Other income 504 2,000 3,304 7,878
Expenses related to convertible notes payable:        
Change in fair value of derivative liability 61,553   (12,189) 1,842,000
Interest accretion (153,515) (25,370) (389,628) (49,660)
Interest expense related to Equity Purchase Agreement (Note 11)   (2,143,500)
Interest expense (606,740) (101,766) (2,044,936) (724,129)
Total Other Income (Expense) (698,198) (125,136) (2,443,449) (1,067,411)
Net Loss before Income Taxes (1,480,386) (1,077,339) (5,960,453) (3,878,517)
Income taxes (Note 9)
Net Loss $ (1,480,386) $ (1,077,339) $ (5,960,453) $ (3,878,517)
Net Basic and Fully Diluted Loss Per Share (in Dollars per share) $ (0.0693) $ (0.0636) $ (0.2791) $ (0.2325)
Weighted average common shares outstanding        
Basic (in Shares) 21,353,550 16,939,276 21,353,550 16,679,847
Fully diluted (in Shares) 22,953,550 16,945,205 22,953,550 16,683,828